Abstract:Mounting evidence underscores the pivotal role of the intestinal barrier and its convoluted network with diet and intestinal microbiome in the pathogenesis of inflammatory bowel disease (IBD) and colitis-associated colorectal cancer (CRC). Moreover, the bidirectional association of the intestinal barrier with the liver and brain, known as the gut-brain axis, plays a crucial role in developing complications, including extraintestinal manifestations of IBD and CRC metastasis. Consequently, barrier healing represents a crucial therapeutic target in these inflammatory-dependent disorders, with barrier assessment predicting disease outcomes, response to therapy and extraintestinal manifestations.New advanced technologies are revolutionising our understanding of the barrier paradigm, enabling the accurate assessment of the intestinal barrier and aiding in unravelling the complexity of the gut-brain axis. Cutting-edge endoscopic imaging techniques, such as ultra-high magnification endocytoscopy and probe-based confocal laser endomicroscopy, are new technologies allowing real-time exploration of the 'cellular' intestinal barrier. Additionally, novel advanced spatial imaging technology platforms, including multispectral imaging, upconversion nanoparticles, digital spatial profiling, optical spectroscopy and mass cytometry, enable a deep and comprehensive assessment of the 'molecular' and 'ultrastructural' barrier. In this promising landscape, artificial intelligence plays a pivotal role in standardising and integrating these novel tools, thereby contributing to barrier assessment and prediction of outcomes.Looking ahead, this integrated and comprehensive approach holds the promise of uncovering new therapeutic targets, breaking the therapeutic ceiling in IBD. Novel molecules, dietary interventions and microbiome modulation strategies aim to restore, reinforce, or modulate the gut-brain axis. These advancements have the potential for transformative and personalised approaches to managing IBD.

Intestinal permeability in disorders of gut-brain interaction (DGBI): From bench to bedside

The role of the gut microbiome in disorders of gut–brain interaction

The Role of Intestinal Permeability in Gastrointestinal Disorders and Current Methods of Evaluation

Intestinal Barrier Impairment, Preservation, and Repair: An Update

Intestinal permeation and gastrointestinal disease

Intestinal Barrier Dysfunction in Inflammatory Bowel Disease: Underpinning Pathogenesis and Therapeutics

"Sentinel or accomplice": gut microbiota and microglia crosstalk in disorders of gut-brain interaction

Intestinal Barrier and Behavior

Human Intestinal Barrier Function in Health and Disease

Impact of gut-brain interaction in emerging neurological disorders

Opening the doors of precision medicine: novel tools to assess intestinal barrier in inflammatory bowel disease and colitis-associated neoplasia

The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems

Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases

Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut

Deciphering internal and external factors influencing intestinal junctional complexes

Border Control: The Role of the Microbiome in Regulating Epithelial Barrier Function

Nutrition and Disorders of Gut–Brain Interaction

Intestinal barrier dysfunction in irritable bowel syndrome: a systematic review

Gastrointestinal and brain barriers: unlocking gates of communication across the microbiota–gut–brain axis

Intestinal epithelial barrier dysfunction in disease and possible therapeutical interventions

Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier